FROM NEUTRON TO PATIENT

Welcome to the Brand page for “FROM NEUTRON TO PATIENT”, which is offered here for Pharmaceutical preparations for the diagnosis and treatment of cancer and tumors; pharmaceutical preparations for the diagnosis and treatment of oncological diseases; radioactive pharmaceutical substances for use in nuclear medicine, intended for medical treatments and imaging; drug delivery agents consisting of compounds that facilitate delivery of a wide range of pharmaceuticals;pharmaceutical research and development services; providing medical research information in the fields of pharmaceuticals, oncology and nuclear medicine;.

Its status is currently believed to be active. Its class is unavailable. “FROM NEUTRON TO PATIENT” is believed to be currently owned by “POINT Biopharma USA Inc.”